All ten lose ground as brutal winter 2022 wrecks havoc with Covid Vaccine Stocks. Novavax's return falls to 593% after giving back 108% return on the week.
Sorrento and Arcturus edge up a spot in the top ten because they lost less ground than their compatriots.
The Covid Vaccine Stocks have now slipped back to just 101% return overall. Gains blasted by the winter of '22.
No comments:
Post a Comment